Study identification

PURI

https://redirect.ema.europa.eu/resource/1000000426

EU PAS number

EUPAS1000000426

Study ID

1000000426

Official title and acronym

Sustainability of the Achieving Clinical Audits with Electronic Records (ACAER) Asthma and COPD Quality Improvement Program on Patient Outcomes

DARWIN EU® study

No

Study countries

Australia

Study description

This project focuses on preventing high cost/high burden respiratory events through the harnessing, coordination, dissemination and scaling up of an evidence-based clinical audit model (ACAER Quality improvement program) into general practice. It aligns with national strategies for quality improvement in general practice, hence utilised current general practice infrastructure.

The real-world effectiveness and sustainability of the ACAER QI program in supporting primary care providers in quality improvement initiatives across asthma and COPD care was assessed. Impact was evaluated based on changes in maintenance treatment and exacerbation rates.

Study status

Planned
Research institutions and networks

Institutions

The Woolcock Institute of Medical Research

Networks

Respiratory Effectiveness Group (REG)
Belgium
Denmark
France
Germany
Greece
Hungary
Italy
Netherlands
Spain
Sweden
United Kingdom
First published:
04/06/2024
Network
ENCePP partner

Contact details

David Price

Primary lead investigator
ORCID number:
0000-0002-9728-9992
Study timelines

Date when funding contract was signed

Planned:

Study start date

Planned:

Date of final study report

Planned:
Sources of funding
Other
Pharmaceutical company and other private sector 

More details on funding

Funding for this study was partially provided by Optimum Patient Care Australia and GlaxoSmithKline (GSK).
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable